Global Induced Pluripotent Stem Cells (iPSc) Market Research Report 2025(Status and Outlook)
Report Overview
The market for Induced Pluripotent Stem Cells (iPSc) is driven by advancements in regenerative medicine, drug discovery, and disease modeling. iPSc technology, which involves reprogramming adult somatic cells into a pluripotent state, offers significant advantages over embryonic stem cells, including ethical acceptability and patient-specific applications. Key growth factors include increasing funding for stem cell research, rising prevalence of chronic diseases, and the demand for personalized medicine. Pharmaceutical and biotechnology companies are leveraging iPSc for toxicology screening and drug development, while academic and research institutions utilize them for studying disease mechanisms. Geographically, North America leads the market due to strong R&D investments and regulatory support, followed by Asia-Pacific, where Japan and China are emerging as hubs for iPSc research. However, high costs, technical complexities, and regulatory hurdles remain challenges. The competitive landscape features both established biotech firms and specialized startups, with collaborations and partnerships accelerating commercialization. As innovations in gene editing and 3D bioprinting expand iPSc applications, the market is projected to grow steadily, supported by increasing clinical trials and therapeutic potential.
The global Induced Pluripotent Stem Cells (iPSc) market size was estimated at USD 144.63 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 12.10% during the forecast period.
This report provides a deep insight into the global Induced Pluripotent Stem Cells (iPSc) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Induced Pluripotent Stem Cells (iPSc) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Induced Pluripotent Stem Cells (iPSc) market in any manner.
Global Induced Pluripotent Stem Cells (iPSc) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Lonza
Axol Bioscience Ltd.
Evotec
Hitachi Ltd.
Merck KGaA
REPROCELL Inc.
Fate Therapeutics
Thermo Fisher Scientific, Inc.
StemCellFactory III
Applied StemCell Inc.
Fujifilm Holding Corporation (CDI)
Ncardia
Sumitomo Dainippon harma
Astellas Pharma Inc
Pluricell Biotech
Cell Inspire Biotechnology
Market Segmentation (by Type)
Hepatocytes
Fibroblasts
Keratinocytes
Amniotic Cells
Market Segmentation (by Application)
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Induced Pluripotent Stem Cells (iPSc) Market
Overview of the regional outlook of the Induced Pluripotent Stem Cells (iPSc) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Induced Pluripotent Stem Cells (iPSc) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Induced Pluripotent Stem Cells (iPSc), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The market for Induced Pluripotent Stem Cells (iPSc) is driven by advancements in regenerative medicine, drug discovery, and disease modeling. iPSc technology, which involves reprogramming adult somatic cells into a pluripotent state, offers significant advantages over embryonic stem cells, including ethical acceptability and patient-specific applications. Key growth factors include increasing funding for stem cell research, rising prevalence of chronic diseases, and the demand for personalized medicine. Pharmaceutical and biotechnology companies are leveraging iPSc for toxicology screening and drug development, while academic and research institutions utilize them for studying disease mechanisms. Geographically, North America leads the market due to strong R&D investments and regulatory support, followed by Asia-Pacific, where Japan and China are emerging as hubs for iPSc research. However, high costs, technical complexities, and regulatory hurdles remain challenges. The competitive landscape features both established biotech firms and specialized startups, with collaborations and partnerships accelerating commercialization. As innovations in gene editing and 3D bioprinting expand iPSc applications, the market is projected to grow steadily, supported by increasing clinical trials and therapeutic potential.
The global Induced Pluripotent Stem Cells (iPSc) market size was estimated at USD 144.63 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 12.10% during the forecast period.
This report provides a deep insight into the global Induced Pluripotent Stem Cells (iPSc) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Induced Pluripotent Stem Cells (iPSc) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Induced Pluripotent Stem Cells (iPSc) market in any manner.
Global Induced Pluripotent Stem Cells (iPSc) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Lonza
Axol Bioscience Ltd.
Evotec
Hitachi Ltd.
Merck KGaA
REPROCELL Inc.
Fate Therapeutics
Thermo Fisher Scientific, Inc.
StemCellFactory III
Applied StemCell Inc.
Fujifilm Holding Corporation (CDI)
Ncardia
Sumitomo Dainippon harma
Astellas Pharma Inc
Pluricell Biotech
Cell Inspire Biotechnology
Market Segmentation (by Type)
Hepatocytes
Fibroblasts
Keratinocytes
Amniotic Cells
Market Segmentation (by Application)
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Induced Pluripotent Stem Cells (iPSc) Market
Overview of the regional outlook of the Induced Pluripotent Stem Cells (iPSc) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Induced Pluripotent Stem Cells (iPSc) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Induced Pluripotent Stem Cells (iPSc), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Induced Pluripotent Stem Cells (iPSc)
1.2 Key Market Segments
1.2.1 Induced Pluripotent Stem Cells (iPSc) Segment by Type
1.2.2 Induced Pluripotent Stem Cells (iPSc) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INDUCED PLURIPOTENT STEM CELLS (IPSC) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Induced Pluripotent Stem Cells (iPSc) Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INDUCED PLURIPOTENT STEM CELLS (IPSC) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Induced Pluripotent Stem Cells (iPSc) Product Life Cycle
3.3 Global Induced Pluripotent Stem Cells (iPSc) Sales by Manufacturers (2020-2025)
3.4 Global Induced Pluripotent Stem Cells (iPSc) Revenue Market Share by Manufacturers (2020-2025)
3.5 Induced Pluripotent Stem Cells (iPSc) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Induced Pluripotent Stem Cells (iPSc) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Induced Pluripotent Stem Cells (iPSc) Market Competitive Situation and Trends
3.8.1 Induced Pluripotent Stem Cells (iPSc) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Induced Pluripotent Stem Cells (iPSc) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INDUCED PLURIPOTENT STEM CELLS (IPSC) INDUSTRY CHAIN ANALYSIS
4.1 Induced Pluripotent Stem Cells (iPSc) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INDUCED PLURIPOTENT STEM CELLS (IPSC) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Induced Pluripotent Stem Cells (iPSc) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Induced Pluripotent Stem Cells (iPSc) Market
5.7 ESG Ratings of Leading Companies
6 INDUCED PLURIPOTENT STEM CELLS (IPSC) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Type (2020-2025)
6.3 Global Induced Pluripotent Stem Cells (iPSc) Market Size Market Share by Type (2020-2025)
6.4 Global Induced Pluripotent Stem Cells (iPSc) Price by Type (2020-2025)
7 INDUCED PLURIPOTENT STEM CELLS (IPSC) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Induced Pluripotent Stem Cells (iPSc) Market Sales by Application (2020-2025)
7.3 Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) by Application (2020-2025)
7.4 Global Induced Pluripotent Stem Cells (iPSc) Sales Growth Rate by Application (2020-2025)
8 INDUCED PLURIPOTENT STEM CELLS (IPSC) MARKET SALES BY REGION
8.1 Global Induced Pluripotent Stem Cells (iPSc) Sales by Region
8.1.1 Global Induced Pluripotent Stem Cells (iPSc) Sales by Region
8.1.2 Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region
8.2 Global Induced Pluripotent Stem Cells (iPSc) Market Size by Region
8.2.1 Global Induced Pluripotent Stem Cells (iPSc) Market Size by Region
8.2.2 Global Induced Pluripotent Stem Cells (iPSc) Market Size Market Share by Region
8.3 North America
8.3.1 North America Induced Pluripotent Stem Cells (iPSc) Sales by Country
8.3.2 North America Induced Pluripotent Stem Cells (iPSc) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Induced Pluripotent Stem Cells (iPSc) Sales by Country
8.4.2 Europe Induced Pluripotent Stem Cells (iPSc) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales by Region
8.5.2 Asia Pacific Induced Pluripotent Stem Cells (iPSc) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Induced Pluripotent Stem Cells (iPSc) Sales by Country
8.6.2 South America Induced Pluripotent Stem Cells (iPSc) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Sales by Region
8.7.2 Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INDUCED PLURIPOTENT STEM CELLS (IPSC) MARKET PRODUCTION BY REGION
9.1 Global Production of Induced Pluripotent Stem Cells (iPSc) by Region(2020-2025)
9.2 Global Induced Pluripotent Stem Cells (iPSc) Revenue Market Share by Region (2020-2025)
9.3 Global Induced Pluripotent Stem Cells (iPSc) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Induced Pluripotent Stem Cells (iPSc) Production
9.4.1 North America Induced Pluripotent Stem Cells (iPSc) Production Growth Rate (2020-2025)
9.4.2 North America Induced Pluripotent Stem Cells (iPSc) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Induced Pluripotent Stem Cells (iPSc) Production
9.5.1 Europe Induced Pluripotent Stem Cells (iPSc) Production Growth Rate (2020-2025)
9.5.2 Europe Induced Pluripotent Stem Cells (iPSc) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Induced Pluripotent Stem Cells (iPSc) Production (2020-2025)
9.6.1 Japan Induced Pluripotent Stem Cells (iPSc) Production Growth Rate (2020-2025)
9.6.2 Japan Induced Pluripotent Stem Cells (iPSc) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Induced Pluripotent Stem Cells (iPSc) Production (2020-2025)
9.7.1 China Induced Pluripotent Stem Cells (iPSc) Production Growth Rate (2020-2025)
9.7.2 China Induced Pluripotent Stem Cells (iPSc) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Lonza
10.1.1 Lonza Basic Information
10.1.2 Lonza Induced Pluripotent Stem Cells (iPSc) Product Overview
10.1.3 Lonza Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.1.4 Lonza Business Overview
10.1.5 Lonza SWOT Analysis
10.1.6 Lonza Recent Developments
10.2 Axol Bioscience Ltd.
10.2.1 Axol Bioscience Ltd. Basic Information
10.2.2 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Product Overview
10.2.3 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.2.4 Axol Bioscience Ltd. Business Overview
10.2.5 Axol Bioscience Ltd. SWOT Analysis
10.2.6 Axol Bioscience Ltd. Recent Developments
10.3 Evotec
10.3.1 Evotec Basic Information
10.3.2 Evotec Induced Pluripotent Stem Cells (iPSc) Product Overview
10.3.3 Evotec Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.3.4 Evotec Business Overview
10.3.5 Evotec SWOT Analysis
10.3.6 Evotec Recent Developments
10.4 Hitachi Ltd.
10.4.1 Hitachi Ltd. Basic Information
10.4.2 Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Product Overview
10.4.3 Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.4.4 Hitachi Ltd. Business Overview
10.4.5 Hitachi Ltd. Recent Developments
10.5 Merck KGaA
10.5.1 Merck KGaA Basic Information
10.5.2 Merck KGaA Induced Pluripotent Stem Cells (iPSc) Product Overview
10.5.3 Merck KGaA Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.5.4 Merck KGaA Business Overview
10.5.5 Merck KGaA Recent Developments
10.6 REPROCELL Inc.
10.6.1 REPROCELL Inc. Basic Information
10.6.2 REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview
10.6.3 REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.6.4 REPROCELL Inc. Business Overview
10.6.5 REPROCELL Inc. Recent Developments
10.7 Fate Therapeutics
10.7.1 Fate Therapeutics Basic Information
10.7.2 Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Product Overview
10.7.3 Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.7.4 Fate Therapeutics Business Overview
10.7.5 Fate Therapeutics Recent Developments
10.8 Thermo Fisher Scientific, Inc.
10.8.1 Thermo Fisher Scientific, Inc. Basic Information
10.8.2 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview
10.8.3 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.8.4 Thermo Fisher Scientific, Inc. Business Overview
10.8.5 Thermo Fisher Scientific, Inc. Recent Developments
10.9 StemCellFactory III
10.9.1 StemCellFactory III Basic Information
10.9.2 StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Product Overview
10.9.3 StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.9.4 StemCellFactory III Business Overview
10.9.5 StemCellFactory III Recent Developments
10.10 Applied StemCell Inc.
10.10.1 Applied StemCell Inc. Basic Information
10.10.2 Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview
10.10.3 Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.10.4 Applied StemCell Inc. Business Overview
10.10.5 Applied StemCell Inc. Recent Developments
10.11 Fujifilm Holding Corporation (CDI)
10.11.1 Fujifilm Holding Corporation (CDI) Basic Information
10.11.2 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Product Overview
10.11.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.11.4 Fujifilm Holding Corporation (CDI) Business Overview
10.11.5 Fujifilm Holding Corporation (CDI) Recent Developments
10.12 Ncardia
10.12.1 Ncardia Basic Information
10.12.2 Ncardia Induced Pluripotent Stem Cells (iPSc) Product Overview
10.12.3 Ncardia Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.12.4 Ncardia Business Overview
10.12.5 Ncardia Recent Developments
10.13 Sumitomo Dainippon harma
10.13.1 Sumitomo Dainippon harma Basic Information
10.13.2 Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Product Overview
10.13.3 Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.13.4 Sumitomo Dainippon harma Business Overview
10.13.5 Sumitomo Dainippon harma Recent Developments
10.14 Astellas Pharma Inc
10.14.1 Astellas Pharma Inc Basic Information
10.14.2 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Product Overview
10.14.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.14.4 Astellas Pharma Inc Business Overview
10.14.5 Astellas Pharma Inc Recent Developments
10.15 Pluricell Biotech
10.15.1 Pluricell Biotech Basic Information
10.15.2 Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Product Overview
10.15.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.15.4 Pluricell Biotech Business Overview
10.15.5 Pluricell Biotech Recent Developments
10.16 Cell Inspire Biotechnology
10.16.1 Cell Inspire Biotechnology Basic Information
10.16.2 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Product Overview
10.16.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.16.4 Cell Inspire Biotechnology Business Overview
10.16.5 Cell Inspire Biotechnology Recent Developments
11 INDUCED PLURIPOTENT STEM CELLS (IPSC) MARKET FORECAST BY REGION
11.1 Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast
11.2 Global Induced Pluripotent Stem Cells (iPSc) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country
11.2.3 Asia Pacific Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Region
11.2.4 South America Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Induced Pluripotent Stem Cells (iPSc) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Induced Pluripotent Stem Cells (iPSc) Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Induced Pluripotent Stem Cells (iPSc) by Type (2026-2033)
12.1.2 Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Induced Pluripotent Stem Cells (iPSc) by Type (2026-2033)
12.2 Global Induced Pluripotent Stem Cells (iPSc) Market Forecast by Application (2026-2033)
12.2.1 Global Induced Pluripotent Stem Cells (iPSc) Sales (K MT) Forecast by Application
12.2.2 Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Induced Pluripotent Stem Cells (iPSc)
1.2 Key Market Segments
1.2.1 Induced Pluripotent Stem Cells (iPSc) Segment by Type
1.2.2 Induced Pluripotent Stem Cells (iPSc) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INDUCED PLURIPOTENT STEM CELLS (IPSC) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Induced Pluripotent Stem Cells (iPSc) Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INDUCED PLURIPOTENT STEM CELLS (IPSC) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Induced Pluripotent Stem Cells (iPSc) Product Life Cycle
3.3 Global Induced Pluripotent Stem Cells (iPSc) Sales by Manufacturers (2020-2025)
3.4 Global Induced Pluripotent Stem Cells (iPSc) Revenue Market Share by Manufacturers (2020-2025)
3.5 Induced Pluripotent Stem Cells (iPSc) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Induced Pluripotent Stem Cells (iPSc) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Induced Pluripotent Stem Cells (iPSc) Market Competitive Situation and Trends
3.8.1 Induced Pluripotent Stem Cells (iPSc) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Induced Pluripotent Stem Cells (iPSc) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INDUCED PLURIPOTENT STEM CELLS (IPSC) INDUSTRY CHAIN ANALYSIS
4.1 Induced Pluripotent Stem Cells (iPSc) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INDUCED PLURIPOTENT STEM CELLS (IPSC) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Induced Pluripotent Stem Cells (iPSc) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Induced Pluripotent Stem Cells (iPSc) Market
5.7 ESG Ratings of Leading Companies
6 INDUCED PLURIPOTENT STEM CELLS (IPSC) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Type (2020-2025)
6.3 Global Induced Pluripotent Stem Cells (iPSc) Market Size Market Share by Type (2020-2025)
6.4 Global Induced Pluripotent Stem Cells (iPSc) Price by Type (2020-2025)
7 INDUCED PLURIPOTENT STEM CELLS (IPSC) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Induced Pluripotent Stem Cells (iPSc) Market Sales by Application (2020-2025)
7.3 Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) by Application (2020-2025)
7.4 Global Induced Pluripotent Stem Cells (iPSc) Sales Growth Rate by Application (2020-2025)
8 INDUCED PLURIPOTENT STEM CELLS (IPSC) MARKET SALES BY REGION
8.1 Global Induced Pluripotent Stem Cells (iPSc) Sales by Region
8.1.1 Global Induced Pluripotent Stem Cells (iPSc) Sales by Region
8.1.2 Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region
8.2 Global Induced Pluripotent Stem Cells (iPSc) Market Size by Region
8.2.1 Global Induced Pluripotent Stem Cells (iPSc) Market Size by Region
8.2.2 Global Induced Pluripotent Stem Cells (iPSc) Market Size Market Share by Region
8.3 North America
8.3.1 North America Induced Pluripotent Stem Cells (iPSc) Sales by Country
8.3.2 North America Induced Pluripotent Stem Cells (iPSc) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Induced Pluripotent Stem Cells (iPSc) Sales by Country
8.4.2 Europe Induced Pluripotent Stem Cells (iPSc) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales by Region
8.5.2 Asia Pacific Induced Pluripotent Stem Cells (iPSc) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Induced Pluripotent Stem Cells (iPSc) Sales by Country
8.6.2 South America Induced Pluripotent Stem Cells (iPSc) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Sales by Region
8.7.2 Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INDUCED PLURIPOTENT STEM CELLS (IPSC) MARKET PRODUCTION BY REGION
9.1 Global Production of Induced Pluripotent Stem Cells (iPSc) by Region(2020-2025)
9.2 Global Induced Pluripotent Stem Cells (iPSc) Revenue Market Share by Region (2020-2025)
9.3 Global Induced Pluripotent Stem Cells (iPSc) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Induced Pluripotent Stem Cells (iPSc) Production
9.4.1 North America Induced Pluripotent Stem Cells (iPSc) Production Growth Rate (2020-2025)
9.4.2 North America Induced Pluripotent Stem Cells (iPSc) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Induced Pluripotent Stem Cells (iPSc) Production
9.5.1 Europe Induced Pluripotent Stem Cells (iPSc) Production Growth Rate (2020-2025)
9.5.2 Europe Induced Pluripotent Stem Cells (iPSc) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Induced Pluripotent Stem Cells (iPSc) Production (2020-2025)
9.6.1 Japan Induced Pluripotent Stem Cells (iPSc) Production Growth Rate (2020-2025)
9.6.2 Japan Induced Pluripotent Stem Cells (iPSc) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Induced Pluripotent Stem Cells (iPSc) Production (2020-2025)
9.7.1 China Induced Pluripotent Stem Cells (iPSc) Production Growth Rate (2020-2025)
9.7.2 China Induced Pluripotent Stem Cells (iPSc) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Lonza
10.1.1 Lonza Basic Information
10.1.2 Lonza Induced Pluripotent Stem Cells (iPSc) Product Overview
10.1.3 Lonza Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.1.4 Lonza Business Overview
10.1.5 Lonza SWOT Analysis
10.1.6 Lonza Recent Developments
10.2 Axol Bioscience Ltd.
10.2.1 Axol Bioscience Ltd. Basic Information
10.2.2 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Product Overview
10.2.3 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.2.4 Axol Bioscience Ltd. Business Overview
10.2.5 Axol Bioscience Ltd. SWOT Analysis
10.2.6 Axol Bioscience Ltd. Recent Developments
10.3 Evotec
10.3.1 Evotec Basic Information
10.3.2 Evotec Induced Pluripotent Stem Cells (iPSc) Product Overview
10.3.3 Evotec Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.3.4 Evotec Business Overview
10.3.5 Evotec SWOT Analysis
10.3.6 Evotec Recent Developments
10.4 Hitachi Ltd.
10.4.1 Hitachi Ltd. Basic Information
10.4.2 Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Product Overview
10.4.3 Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.4.4 Hitachi Ltd. Business Overview
10.4.5 Hitachi Ltd. Recent Developments
10.5 Merck KGaA
10.5.1 Merck KGaA Basic Information
10.5.2 Merck KGaA Induced Pluripotent Stem Cells (iPSc) Product Overview
10.5.3 Merck KGaA Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.5.4 Merck KGaA Business Overview
10.5.5 Merck KGaA Recent Developments
10.6 REPROCELL Inc.
10.6.1 REPROCELL Inc. Basic Information
10.6.2 REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview
10.6.3 REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.6.4 REPROCELL Inc. Business Overview
10.6.5 REPROCELL Inc. Recent Developments
10.7 Fate Therapeutics
10.7.1 Fate Therapeutics Basic Information
10.7.2 Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Product Overview
10.7.3 Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.7.4 Fate Therapeutics Business Overview
10.7.5 Fate Therapeutics Recent Developments
10.8 Thermo Fisher Scientific, Inc.
10.8.1 Thermo Fisher Scientific, Inc. Basic Information
10.8.2 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview
10.8.3 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.8.4 Thermo Fisher Scientific, Inc. Business Overview
10.8.5 Thermo Fisher Scientific, Inc. Recent Developments
10.9 StemCellFactory III
10.9.1 StemCellFactory III Basic Information
10.9.2 StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Product Overview
10.9.3 StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.9.4 StemCellFactory III Business Overview
10.9.5 StemCellFactory III Recent Developments
10.10 Applied StemCell Inc.
10.10.1 Applied StemCell Inc. Basic Information
10.10.2 Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview
10.10.3 Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.10.4 Applied StemCell Inc. Business Overview
10.10.5 Applied StemCell Inc. Recent Developments
10.11 Fujifilm Holding Corporation (CDI)
10.11.1 Fujifilm Holding Corporation (CDI) Basic Information
10.11.2 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Product Overview
10.11.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.11.4 Fujifilm Holding Corporation (CDI) Business Overview
10.11.5 Fujifilm Holding Corporation (CDI) Recent Developments
10.12 Ncardia
10.12.1 Ncardia Basic Information
10.12.2 Ncardia Induced Pluripotent Stem Cells (iPSc) Product Overview
10.12.3 Ncardia Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.12.4 Ncardia Business Overview
10.12.5 Ncardia Recent Developments
10.13 Sumitomo Dainippon harma
10.13.1 Sumitomo Dainippon harma Basic Information
10.13.2 Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Product Overview
10.13.3 Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.13.4 Sumitomo Dainippon harma Business Overview
10.13.5 Sumitomo Dainippon harma Recent Developments
10.14 Astellas Pharma Inc
10.14.1 Astellas Pharma Inc Basic Information
10.14.2 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Product Overview
10.14.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.14.4 Astellas Pharma Inc Business Overview
10.14.5 Astellas Pharma Inc Recent Developments
10.15 Pluricell Biotech
10.15.1 Pluricell Biotech Basic Information
10.15.2 Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Product Overview
10.15.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.15.4 Pluricell Biotech Business Overview
10.15.5 Pluricell Biotech Recent Developments
10.16 Cell Inspire Biotechnology
10.16.1 Cell Inspire Biotechnology Basic Information
10.16.2 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Product Overview
10.16.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Product Market Performance
10.16.4 Cell Inspire Biotechnology Business Overview
10.16.5 Cell Inspire Biotechnology Recent Developments
11 INDUCED PLURIPOTENT STEM CELLS (IPSC) MARKET FORECAST BY REGION
11.1 Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast
11.2 Global Induced Pluripotent Stem Cells (iPSc) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country
11.2.3 Asia Pacific Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Region
11.2.4 South America Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Induced Pluripotent Stem Cells (iPSc) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Induced Pluripotent Stem Cells (iPSc) Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Induced Pluripotent Stem Cells (iPSc) by Type (2026-2033)
12.1.2 Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Induced Pluripotent Stem Cells (iPSc) by Type (2026-2033)
12.2 Global Induced Pluripotent Stem Cells (iPSc) Market Forecast by Application (2026-2033)
12.2.1 Global Induced Pluripotent Stem Cells (iPSc) Sales (K MT) Forecast by Application
12.2.2 Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Induced Pluripotent Stem Cells (iPSc) Market Size Comparison by Region (M USD)
Table 5. Global Induced Pluripotent Stem Cells (iPSc) Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Induced Pluripotent Stem Cells (iPSc) Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Induced Pluripotent Stem Cells (iPSc) Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Induced Pluripotent Stem Cells (iPSc) as of 2024)
Table 10. Global Market Induced Pluripotent Stem Cells (iPSc) Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Induced Pluripotent Stem Cells (iPSc) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Induced Pluripotent Stem Cells (iPSc) Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Induced Pluripotent Stem Cells (iPSc) Sales by Type (K MT)
Table 26. Global Induced Pluripotent Stem Cells (iPSc) Market Size by Type (M USD)
Table 27. Global Induced Pluripotent Stem Cells (iPSc) Sales (K MT) by Type (2020-2025)
Table 28. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Type (2020-2025)
Table 29. Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) by Type (2020-2025)
Table 30. Global Induced Pluripotent Stem Cells (iPSc) Market Size Share by Type (2020-2025)
Table 31. Global Induced Pluripotent Stem Cells (iPSc) Price (USD/KG) by Type (2020-2025)
Table 32. Global Induced Pluripotent Stem Cells (iPSc) Sales (K MT) by Application
Table 33. Global Induced Pluripotent Stem Cells (iPSc) Market Size by Application
Table 34. Global Induced Pluripotent Stem Cells (iPSc) Sales by Application (2020-2025) & (K MT)
Table 35. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Application (2020-2025)
Table 36. Global Induced Pluripotent Stem Cells (iPSc) Market Size by Application (2020-2025) & (M USD)
Table 37. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Application (2020-2025)
Table 38. Global Induced Pluripotent Stem Cells (iPSc) Sales Growth Rate by Application (2020-2025)
Table 39. Global Induced Pluripotent Stem Cells (iPSc) Sales by Region (2020-2025) & (K MT)
Table 40. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region (2020-2025)
Table 41. Global Induced Pluripotent Stem Cells (iPSc) Market Size by Region (2020-2025) & (M USD)
Table 42. Global Induced Pluripotent Stem Cells (iPSc) Market Size Market Share by Region (2020-2025)
Table 43. North America Induced Pluripotent Stem Cells (iPSc) Sales by Country (2020-2025) & (K MT)
Table 44. North America Induced Pluripotent Stem Cells (iPSc) Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Induced Pluripotent Stem Cells (iPSc) Sales by Country (2020-2025) & (K MT)
Table 46. Europe Induced Pluripotent Stem Cells (iPSc) Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Market Size by Region (2020-2025) & (M USD)
Table 49. South America Induced Pluripotent Stem Cells (iPSc) Sales by Country (2020-2025) & (K MT)
Table 50. South America Induced Pluripotent Stem Cells (iPSc) Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Market Size by Region (2020-2025) & (M USD)
Table 53. Global Induced Pluripotent Stem Cells (iPSc) Production (K MT) by Region(2020-2025)
Table 54. Global Induced Pluripotent Stem Cells (iPSc) Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Induced Pluripotent Stem Cells (iPSc) Revenue Market Share by Region (2020-2025)
Table 56. Global Induced Pluripotent Stem Cells (iPSc) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Induced Pluripotent Stem Cells (iPSc) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Induced Pluripotent Stem Cells (iPSc) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Induced Pluripotent Stem Cells (iPSc) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Induced Pluripotent Stem Cells (iPSc) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Lonza Basic Information
Table 62. Lonza Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 63. Lonza Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Lonza Business Overview
Table 65. Lonza SWOT Analysis
Table 66. Lonza Recent Developments
Table 67. Axol Bioscience Ltd. Basic Information
Table 68. Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 69. Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Axol Bioscience Ltd. Business Overview
Table 71. Axol Bioscience Ltd. SWOT Analysis
Table 72. Axol Bioscience Ltd. Recent Developments
Table 73. Evotec Basic Information
Table 74. Evotec Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 75. Evotec Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Evotec Business Overview
Table 77. Evotec SWOT Analysis
Table 78. Evotec Recent Developments
Table 79. Hitachi Ltd. Basic Information
Table 80. Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 81. Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Hitachi Ltd. Business Overview
Table 83. Hitachi Ltd. Recent Developments
Table 84. Merck KGaA Basic Information
Table 85. Merck KGaA Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 86. Merck KGaA Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Merck KGaA Business Overview
Table 88. Merck KGaA Recent Developments
Table 89. REPROCELL Inc. Basic Information
Table 90. REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 91. REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. REPROCELL Inc. Business Overview
Table 93. REPROCELL Inc. Recent Developments
Table 94. Fate Therapeutics Basic Information
Table 95. Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 96. Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Fate Therapeutics Business Overview
Table 98. Fate Therapeutics Recent Developments
Table 99. Thermo Fisher Scientific, Inc. Basic Information
Table 100. Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 101. Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Thermo Fisher Scientific, Inc. Business Overview
Table 103. Thermo Fisher Scientific, Inc. Recent Developments
Table 104. StemCellFactory III Basic Information
Table 105. StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 106. StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. StemCellFactory III Business Overview
Table 108. StemCellFactory III Recent Developments
Table 109. Applied StemCell Inc. Basic Information
Table 110. Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 111. Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Applied StemCell Inc. Business Overview
Table 113. Applied StemCell Inc. Recent Developments
Table 114. Fujifilm Holding Corporation (CDI) Basic Information
Table 115. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 116. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Fujifilm Holding Corporation (CDI) Business Overview
Table 118. Fujifilm Holding Corporation (CDI) Recent Developments
Table 119. Ncardia Basic Information
Table 120. Ncardia Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 121. Ncardia Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Ncardia Business Overview
Table 123. Ncardia Recent Developments
Table 124. Sumitomo Dainippon harma Basic Information
Table 125. Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 126. Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. Sumitomo Dainippon harma Business Overview
Table 128. Sumitomo Dainippon harma Recent Developments
Table 129. Astellas Pharma Inc Basic Information
Table 130. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 131. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 132. Astellas Pharma Inc Business Overview
Table 133. Astellas Pharma Inc Recent Developments
Table 134. Pluricell Biotech Basic Information
Table 135. Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 136. Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 137. Pluricell Biotech Business Overview
Table 138. Pluricell Biotech Recent Developments
Table 139. Cell Inspire Biotechnology Basic Information
Table 140. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 141. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 142. Cell Inspire Biotechnology Business Overview
Table 143. Cell Inspire Biotechnology Recent Developments
Table 144. Global Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Region (2026-2033) & (K MT)
Table 145. Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Region (2026-2033) & (M USD)
Table 146. North America Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Country (2026-2033) & (K MT)
Table 147. North America Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country (2026-2033) & (M USD)
Table 148. Europe Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Country (2026-2033) & (K MT)
Table 149. Europe Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country (2026-2033) & (M USD)
Table 150. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Region (2026-2033) & (K MT)
Table 151. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Region (2026-2033) & (M USD)
Table 152. South America Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Country (2026-2033) & (K MT)
Table 153. South America Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country (2026-2033) & (M USD)
Table 154. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Country (2026-2033) & (Units)
Table 155. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country (2026-2033) & (M USD)
Table 156. Global Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Type (2026-2033) & (K MT)
Table 157. Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Type (2026-2033) & (M USD)
Table 158. Global Induced Pluripotent Stem Cells (iPSc) Price Forecast by Type (2026-2033) & (USD/KG)
Table 159. Global Induced Pluripotent Stem Cells (iPSc) Sales (K MT) Forecast by Application (2026-2033)
Table 160. Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Induced Pluripotent Stem Cells (iPSc) Market Size Comparison by Region (M USD)
Table 5. Global Induced Pluripotent Stem Cells (iPSc) Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Induced Pluripotent Stem Cells (iPSc) Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Induced Pluripotent Stem Cells (iPSc) Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Induced Pluripotent Stem Cells (iPSc) as of 2024)
Table 10. Global Market Induced Pluripotent Stem Cells (iPSc) Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Induced Pluripotent Stem Cells (iPSc) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Induced Pluripotent Stem Cells (iPSc) Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Induced Pluripotent Stem Cells (iPSc) Sales by Type (K MT)
Table 26. Global Induced Pluripotent Stem Cells (iPSc) Market Size by Type (M USD)
Table 27. Global Induced Pluripotent Stem Cells (iPSc) Sales (K MT) by Type (2020-2025)
Table 28. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Type (2020-2025)
Table 29. Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) by Type (2020-2025)
Table 30. Global Induced Pluripotent Stem Cells (iPSc) Market Size Share by Type (2020-2025)
Table 31. Global Induced Pluripotent Stem Cells (iPSc) Price (USD/KG) by Type (2020-2025)
Table 32. Global Induced Pluripotent Stem Cells (iPSc) Sales (K MT) by Application
Table 33. Global Induced Pluripotent Stem Cells (iPSc) Market Size by Application
Table 34. Global Induced Pluripotent Stem Cells (iPSc) Sales by Application (2020-2025) & (K MT)
Table 35. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Application (2020-2025)
Table 36. Global Induced Pluripotent Stem Cells (iPSc) Market Size by Application (2020-2025) & (M USD)
Table 37. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Application (2020-2025)
Table 38. Global Induced Pluripotent Stem Cells (iPSc) Sales Growth Rate by Application (2020-2025)
Table 39. Global Induced Pluripotent Stem Cells (iPSc) Sales by Region (2020-2025) & (K MT)
Table 40. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region (2020-2025)
Table 41. Global Induced Pluripotent Stem Cells (iPSc) Market Size by Region (2020-2025) & (M USD)
Table 42. Global Induced Pluripotent Stem Cells (iPSc) Market Size Market Share by Region (2020-2025)
Table 43. North America Induced Pluripotent Stem Cells (iPSc) Sales by Country (2020-2025) & (K MT)
Table 44. North America Induced Pluripotent Stem Cells (iPSc) Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Induced Pluripotent Stem Cells (iPSc) Sales by Country (2020-2025) & (K MT)
Table 46. Europe Induced Pluripotent Stem Cells (iPSc) Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Market Size by Region (2020-2025) & (M USD)
Table 49. South America Induced Pluripotent Stem Cells (iPSc) Sales by Country (2020-2025) & (K MT)
Table 50. South America Induced Pluripotent Stem Cells (iPSc) Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Market Size by Region (2020-2025) & (M USD)
Table 53. Global Induced Pluripotent Stem Cells (iPSc) Production (K MT) by Region(2020-2025)
Table 54. Global Induced Pluripotent Stem Cells (iPSc) Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Induced Pluripotent Stem Cells (iPSc) Revenue Market Share by Region (2020-2025)
Table 56. Global Induced Pluripotent Stem Cells (iPSc) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Induced Pluripotent Stem Cells (iPSc) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Induced Pluripotent Stem Cells (iPSc) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Induced Pluripotent Stem Cells (iPSc) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Induced Pluripotent Stem Cells (iPSc) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Lonza Basic Information
Table 62. Lonza Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 63. Lonza Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Lonza Business Overview
Table 65. Lonza SWOT Analysis
Table 66. Lonza Recent Developments
Table 67. Axol Bioscience Ltd. Basic Information
Table 68. Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 69. Axol Bioscience Ltd. Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Axol Bioscience Ltd. Business Overview
Table 71. Axol Bioscience Ltd. SWOT Analysis
Table 72. Axol Bioscience Ltd. Recent Developments
Table 73. Evotec Basic Information
Table 74. Evotec Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 75. Evotec Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Evotec Business Overview
Table 77. Evotec SWOT Analysis
Table 78. Evotec Recent Developments
Table 79. Hitachi Ltd. Basic Information
Table 80. Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 81. Hitachi Ltd. Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Hitachi Ltd. Business Overview
Table 83. Hitachi Ltd. Recent Developments
Table 84. Merck KGaA Basic Information
Table 85. Merck KGaA Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 86. Merck KGaA Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Merck KGaA Business Overview
Table 88. Merck KGaA Recent Developments
Table 89. REPROCELL Inc. Basic Information
Table 90. REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 91. REPROCELL Inc. Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. REPROCELL Inc. Business Overview
Table 93. REPROCELL Inc. Recent Developments
Table 94. Fate Therapeutics Basic Information
Table 95. Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 96. Fate Therapeutics Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Fate Therapeutics Business Overview
Table 98. Fate Therapeutics Recent Developments
Table 99. Thermo Fisher Scientific, Inc. Basic Information
Table 100. Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 101. Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Thermo Fisher Scientific, Inc. Business Overview
Table 103. Thermo Fisher Scientific, Inc. Recent Developments
Table 104. StemCellFactory III Basic Information
Table 105. StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 106. StemCellFactory III Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. StemCellFactory III Business Overview
Table 108. StemCellFactory III Recent Developments
Table 109. Applied StemCell Inc. Basic Information
Table 110. Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 111. Applied StemCell Inc. Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Applied StemCell Inc. Business Overview
Table 113. Applied StemCell Inc. Recent Developments
Table 114. Fujifilm Holding Corporation (CDI) Basic Information
Table 115. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 116. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Fujifilm Holding Corporation (CDI) Business Overview
Table 118. Fujifilm Holding Corporation (CDI) Recent Developments
Table 119. Ncardia Basic Information
Table 120. Ncardia Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 121. Ncardia Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Ncardia Business Overview
Table 123. Ncardia Recent Developments
Table 124. Sumitomo Dainippon harma Basic Information
Table 125. Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 126. Sumitomo Dainippon harma Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. Sumitomo Dainippon harma Business Overview
Table 128. Sumitomo Dainippon harma Recent Developments
Table 129. Astellas Pharma Inc Basic Information
Table 130. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 131. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 132. Astellas Pharma Inc Business Overview
Table 133. Astellas Pharma Inc Recent Developments
Table 134. Pluricell Biotech Basic Information
Table 135. Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 136. Pluricell Biotech Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 137. Pluricell Biotech Business Overview
Table 138. Pluricell Biotech Recent Developments
Table 139. Cell Inspire Biotechnology Basic Information
Table 140. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Product Overview
Table 141. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSc) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 142. Cell Inspire Biotechnology Business Overview
Table 143. Cell Inspire Biotechnology Recent Developments
Table 144. Global Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Region (2026-2033) & (K MT)
Table 145. Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Region (2026-2033) & (M USD)
Table 146. North America Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Country (2026-2033) & (K MT)
Table 147. North America Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country (2026-2033) & (M USD)
Table 148. Europe Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Country (2026-2033) & (K MT)
Table 149. Europe Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country (2026-2033) & (M USD)
Table 150. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Region (2026-2033) & (K MT)
Table 151. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Region (2026-2033) & (M USD)
Table 152. South America Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Country (2026-2033) & (K MT)
Table 153. South America Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country (2026-2033) & (M USD)
Table 154. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Country (2026-2033) & (Units)
Table 155. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Country (2026-2033) & (M USD)
Table 156. Global Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Type (2026-2033) & (K MT)
Table 157. Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Type (2026-2033) & (M USD)
Table 158. Global Induced Pluripotent Stem Cells (iPSc) Price Forecast by Type (2026-2033) & (USD/KG)
Table 159. Global Induced Pluripotent Stem Cells (iPSc) Sales (K MT) Forecast by Application (2026-2033)
Table 160. Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Induced Pluripotent Stem Cells (iPSc)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD), 2024-2033
Figure 5. Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) (2020-2033)
Figure 6. Global Induced Pluripotent Stem Cells (iPSc) Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Induced Pluripotent Stem Cells (iPSc) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Induced Pluripotent Stem Cells (iPSc) Product Life Cycle
Figure 13. Induced Pluripotent Stem Cells (iPSc) Sales Share by Manufacturers in 2024
Figure 14. Global Induced Pluripotent Stem Cells (iPSc) Revenue Share by Manufacturers in 2024
Figure 15. Induced Pluripotent Stem Cells (iPSc) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Induced Pluripotent Stem Cells (iPSc) Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Induced Pluripotent Stem Cells (iPSc) Revenue in 2024
Figure 18. Industry Chain Map of Induced Pluripotent Stem Cells (iPSc)
Figure 19. Global Induced Pluripotent Stem Cells (iPSc) Market PEST Analysis
Figure 20. Global Induced Pluripotent Stem Cells (iPSc) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Type
Figure 27. Sales Market Share of Induced Pluripotent Stem Cells (iPSc) by Type (2020-2025)
Figure 28. Sales Market Share of Induced Pluripotent Stem Cells (iPSc) by Type in 2024
Figure 29. Market Size Share of Induced Pluripotent Stem Cells (iPSc) by Type (2020-2025)
Figure 30. Market Size Share of Induced Pluripotent Stem Cells (iPSc) by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Application
Figure 33. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Application (2020-2025)
Figure 34. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Application in 2024
Figure 35. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Application (2020-2025)
Figure 36. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Application in 2024
Figure 37. Global Induced Pluripotent Stem Cells (iPSc) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region (2020-2025)
Figure 39. Global Induced Pluripotent Stem Cells (iPSc) Market Size Market Share by Region (2020-2025)
Figure 40. North America Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Country in 2024
Figure 43. North America Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Induced Pluripotent Stem Cells (iPSc) Market Size Market Share by Country in 2024
Figure 45. U.S. Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Induced Pluripotent Stem Cells (iPSc) Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Induced Pluripotent Stem Cells (iPSc) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Induced Pluripotent Stem Cells (iPSc) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Country in 2024
Figure 53. Europe Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Induced Pluripotent Stem Cells (iPSc) Market Size Market Share by Country in 2024
Figure 55. Germany Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Market Size Market Share by Region in 2024
Figure 68. China Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (K MT)
Figure 79. South America Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Country in 2024
Figure 80. South America Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (M USD)
Figure 81. South America Induced Pluripotent Stem Cells (iPSc) Market Size Market Share by Country in 2024
Figure 82. Brazil Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Induced Pluripotent Stem Cells (iPSc) Production Market Share by Region (2020-2025)
Figure 103. North America Induced Pluripotent Stem Cells (iPSc) Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Induced Pluripotent Stem Cells (iPSc) Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Induced Pluripotent Stem Cells (iPSc) Production (K MT) Growth Rate (2020-2025)
Figure 106. China Induced Pluripotent Stem Cells (iPSc) Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Induced Pluripotent Stem Cells (iPSc) Market Share Forecast by Type (2026-2033)
Figure 111. Global Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Application (2026-2033)
Figure 112. Global Induced Pluripotent Stem Cells (iPSc) Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Induced Pluripotent Stem Cells (iPSc)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD), 2024-2033
Figure 5. Global Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) (2020-2033)
Figure 6. Global Induced Pluripotent Stem Cells (iPSc) Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Induced Pluripotent Stem Cells (iPSc) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Induced Pluripotent Stem Cells (iPSc) Product Life Cycle
Figure 13. Induced Pluripotent Stem Cells (iPSc) Sales Share by Manufacturers in 2024
Figure 14. Global Induced Pluripotent Stem Cells (iPSc) Revenue Share by Manufacturers in 2024
Figure 15. Induced Pluripotent Stem Cells (iPSc) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Induced Pluripotent Stem Cells (iPSc) Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Induced Pluripotent Stem Cells (iPSc) Revenue in 2024
Figure 18. Industry Chain Map of Induced Pluripotent Stem Cells (iPSc)
Figure 19. Global Induced Pluripotent Stem Cells (iPSc) Market PEST Analysis
Figure 20. Global Induced Pluripotent Stem Cells (iPSc) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Type
Figure 27. Sales Market Share of Induced Pluripotent Stem Cells (iPSc) by Type (2020-2025)
Figure 28. Sales Market Share of Induced Pluripotent Stem Cells (iPSc) by Type in 2024
Figure 29. Market Size Share of Induced Pluripotent Stem Cells (iPSc) by Type (2020-2025)
Figure 30. Market Size Share of Induced Pluripotent Stem Cells (iPSc) by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Application
Figure 33. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Application (2020-2025)
Figure 34. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Application in 2024
Figure 35. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Application (2020-2025)
Figure 36. Global Induced Pluripotent Stem Cells (iPSc) Market Share by Application in 2024
Figure 37. Global Induced Pluripotent Stem Cells (iPSc) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region (2020-2025)
Figure 39. Global Induced Pluripotent Stem Cells (iPSc) Market Size Market Share by Region (2020-2025)
Figure 40. North America Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Country in 2024
Figure 43. North America Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Induced Pluripotent Stem Cells (iPSc) Market Size Market Share by Country in 2024
Figure 45. U.S. Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Induced Pluripotent Stem Cells (iPSc) Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Induced Pluripotent Stem Cells (iPSc) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Induced Pluripotent Stem Cells (iPSc) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Induced Pluripotent Stem Cells (iPSc) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Country in 2024
Figure 53. Europe Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Induced Pluripotent Stem Cells (iPSc) Market Size Market Share by Country in 2024
Figure 55. Germany Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Induced Pluripotent Stem Cells (iPSc) Market Size Market Share by Region in 2024
Figure 68. China Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (K MT)
Figure 79. South America Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Country in 2024
Figure 80. South America Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (M USD)
Figure 81. South America Induced Pluripotent Stem Cells (iPSc) Market Size Market Share by Country in 2024
Figure 82. Brazil Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Induced Pluripotent Stem Cells (iPSc) Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Induced Pluripotent Stem Cells (iPSc) Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Induced Pluripotent Stem Cells (iPSc) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Induced Pluripotent Stem Cells (iPSc) Production Market Share by Region (2020-2025)
Figure 103. North America Induced Pluripotent Stem Cells (iPSc) Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Induced Pluripotent Stem Cells (iPSc) Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Induced Pluripotent Stem Cells (iPSc) Production (K MT) Growth Rate (2020-2025)
Figure 106. China Induced Pluripotent Stem Cells (iPSc) Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Induced Pluripotent Stem Cells (iPSc) Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Induced Pluripotent Stem Cells (iPSc) Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Induced Pluripotent Stem Cells (iPSc) Market Share Forecast by Type (2026-2033)
Figure 111. Global Induced Pluripotent Stem Cells (iPSc) Sales Forecast by Application (2026-2033)
Figure 112. Global Induced Pluripotent Stem Cells (iPSc) Market Share Forecast by Application (2026-2033)
